Chromosomal aberrations in lymphocytes predict human cancer independently of exposure to carcinogens. European Study Group on Cytogenetic Biomarkers and Health.

An increased risk of cancer in healthy individuals with high levels of chromosomal aberrations (CAs) in peripheral blood lymphocytes has been described in recent epidemiological studies. This association did not appear to be modified by sex, age, country, or time since CA test, whereas the role played by exposure to carcinogens is still uncertain because of the requisite information concerning occupation and lifestyle was lacking. We evaluated in the present study whether CAs predicted cancer because they were the result of past exposure to carcinogens or because they were an intermediate end point in the pathway leading to disease. A nested case-control study was performed on 93 incident cancer cases and 62 deceased cancer cases coming from two prospective cohort studies performed in Nordic countries (Denmark, Finland, Norway, and Sweden) and Italy. For each case, four controls matched by country, sex, year of birth, and year of CA test were randomly selected. Occupational exposure and smoking habit were assessed by a collaborative group of occupational hygienists. Logistic regression models indicated a statistically significant increase in risk for subjects with a high level of CAs compared to those with a low level in the Nordic cohort (odds ratio, 2.35; 95% confidence interval, 1.31-4.23) and in the Italian cohort (odds ratio, 2.66; 95% confidence interval, 1.26-5.62). These estimates were not affected by the inclusion of occupational exposure level and smoking habit in the regression model. The risk for high versus low levels of CAs was similar in subjects heavily exposed to carcinogens and in those who had never, to their knowledge, been exposed to any major carcinogenic agent during their lifetime, supporting the idea that chromosome damage itself is involved in the pathway to cancer. The results have important ramifications for the understanding of the role played by sporadic chromosome damage for the origin of neoplasia-associated CAs.

[1]  C. J. Chen,et al.  Increased chromosome-type chromosome aberration frequencies as biomarkers of cancer risk in a blackfoot endemic area. , 1999, Cancer research.

[2]  P. S. Nielsen,et al.  Chromosomal aberrations in humans induced by urban air pollution: influence of DNA repair and polymorphisms of glutathione S-transferase M1 and N-acetyltransferase 2. , 1999, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[3]  K. Kinzler,et al.  Genetic instabilities in human cancers , 1998, Nature.

[4]  H. Norppa,et al.  Cancer predictive value of cytogenetic markers used in occupational health surveillance programs: a report from an ongoing study by the European Study Group on Cytogenetic Biomarkers and Health. , 1998, Mutation research.

[5]  H. Norppa,et al.  Chromosomal aberrations in lymphocytes predict human cancer: a report from the European Study Group on Cytogenetic Biomarkers and Health (ESCH). , 1998, Cancer research.

[6]  M. Rossing.  Genetic influences on smoking: candidate genes. , 1998, Environmental health perspectives.

[7]  R. Sram.  Effect of glutathione S-transferase M1 polymorphisms on biomarkers of exposure and effects. , 1998, Environmental health perspectives.

[8]  Gert Auer,et al.  Tumor cytogenetics revisited: comparative genomic hybridization and spectral karyotyping , 1997, Journal of Molecular Medicine.

[9]  H. Norppa.  Cytogenetic markers of susceptibility: influence of polymorphic carcinogen-metabolizing enzymes. , 1997, Environmental health perspectives.

[10]  B. Johansson,et al.  A breakpoint map of recurrent chromosomal rearrangements in human neoplasia , 1997, Nature Genetics.

[11]  B. Ames,et al.  Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[12]  K. Peltonen,et al.  Assessment of exposure to butadiene in the process industry. , 1996, Toxicology.

[13]  S. Bonassi,et al.  Are chromosome aberrations in circulating lymphocytes predictive of future cancer onset in humans? Preliminary results of an Italian cohort study. , 1995, Cancer genetics and cytogenetics.

[14]  A. Brøgger,et al.  Cancer risk in humans predicted by increased levels of chromosomal aberrations in lymphocytes: Nordic study group on the health risk of chromosome damage. , 1994, Cancer research.

[15]  K. Bogen.  Reassessment of human peripheral T-lymphocyte lifespan deduced from cytogenetic and cytotoxic effects of radiation. , 1993, International journal of radiation biology.

[16]  J K McLaughlin,et al.  Selection of controls in case-control studies. III. Design options. , 1992, American journal of epidemiology.

[17]  D. Silverman,et al.  Selection of controls in case-control studies. I. Principles. , 1992, American journal of epidemiology.

[18]  D. Hosmer,et al.  Applied Logistic Regression , 1991 .

[19]  S. Dawsey,et al.  Validation of intermediate end points in cancer research. , 1990, Journal of the National Cancer Institute.

[20]  A. Brøgger,et al.  A Nordic data base on somatic chromosome damage in humans. Nordic Study Group on the Health Risk of Chromosome Damage. , 1990, Mutation research.

[21]  J D Tucker,et al.  Cytogenetic end-points as biological dosimeters and predictors of risk in epidemiological studies. , 1997, IARC scientific publications.

[22]  W. Au,et al.  Interactions between genetic predisposition and environmental toxicants for development of lung cancer , 1997, Environmental and molecular mutagenesis.

[23]  A. McMichael,et al.  The use of biological markers as predictive early-outcome measures in epidemiological research. , 1997, IARC scientific publications.